Newsletter

Subscribe and recieve updates on this company.

Text STOCKS to 72727 for mobile alerts

We are excited to present Pressure BioSciences, Inc. (OTC: PBIO).

Full DD Report for PBIO

You must become a subscriber to view this report.


Recent News from (OTC: PBIO)

NetworkNewsBreaks - Pressure BioSciences Inc. (PBIO) Issued Key U.S. Patent for High-Pressure Flow-Through Microfluidic Sample Preparation Device
Pressure BioSciences (OTCQB: PBIO) this morning announced the award of a key new U.S. patent, entitled ''Flow-through High Hydrostatic Pressure Microfluidic Sample Preparation Device and Related Methods Therefor.'' The company’s creation provides a path for integration of automated ''Ha...
Source: NetworkNewsWire
Date: August, 30 2018 09:00
Pressure BioSciences Awarded Key U.S. Patent for Novel High-Pressure Flow-Through Microfluidic Sample Preparation Device
Invention Opens Path for Integration of Automated ''Hands-Free'' Sample Prep Workflows Utilizing Company's Patented High-Pressure Platform Technologies SOUTH EASTON, MA / ACCESSWIRE / August 30, 2018 / Pressure BioSciences, Inc. (OTCQB: PBIO) (''PBI'' or the ''Company''), a leader in th...
Source: ACCESSWIRE
Date: August, 30 2018 08:00
NetworkNewsBreaks - Zacks Research Report Forecasts Pressure BioSciences Inc. (PBIO) to See Major Annual Growth Over the Next Five Years
Pressure BioSciences (OTCQB: PBIO) was recently covered in a Zacks Research Report issued on July 26, 2018, which forecasted PBIO to grow at a compound annual growth rate (CAGR) of 76 percent in the next five fiscal years from 2018 to 2022 ( http://nnw.fm/F3GhM ). A recent article discuss...
Source: NetworkNewsWire
Date: August, 28 2018 15:15
NetworkNewsBreaks - Pressure BioSciences Inc. (PBIO) Collaborating with Ohio State in Disruptive Technology to Preserve Beverages and Liquid Foods
Pressure BioSciences (OTCQB: PBIO) is collaborating with The Ohio State University and its College of Food, Agricultural and Environmental Sciences (“CFAES”) to create an innovative new method for room temperature storage of beverages and liquid foods without using...
Source: NetworkNewsWire
Date: August, 23 2018 14:45
The MissionIR Newsletter Reports on DJACF, DPW, FRSX, NETE, NUGL, NUGS, PFSF, PBIO, SNNVF, TGODF, TMSR and VVCIF
Every month, MissionIR issues a newsletter to update subscribers with regular updates on featured clients as well as relevant industry news effective the value of your portfolio. Here are the 12 companies featured this month: Foresight Autonomous Holdings Ltd. (NASDAQ: FRSX) (TASE: FRSX) ...
Source: NetworkNewsWire
Date: August, 16 2018 12:30
Pressure BioSciences Inc. (PBIO) Reports Significant Financial and Operational Achievements during Highly Successful Q2
Pressure BioSciences Inc. announced strong financial results for the second quarter of 2018, demonstrating the company’s growth and stability Products and services revenue increased for the tenth consecutive quarter (YoY) while registering growth of 29 percent compared to Q2 2017 ...
Source: NetworkNewsWire
Date: August, 16 2018 11:15
NetworkNewsBreaks - Pressure BioSciences Inc. (PBIO) Reports Q2 2018 Financial Results; Provides Business Update
Pressure BioSciences (OTCQB: PBIO) this morning provided a business update, offered limited guidance for the remainder of 2018 and reported financial results for the second quarter ended June 30, 2018. Per the update, total revenue for the second quarter was $638,800, an increase of 18% compar...
Source: NetworkNewsWire
Date: August, 15 2018 09:00
Pressure BioSciences, Inc. Reports Second Quarter 2018 Financial Results and Provides Business Update
Major Debt to Equity Conversions, Increasing Revenues, and a Significant Operating Loss Decrease Highlight the 2018 Second Quarter Investor Conference Call Scheduled for Wednesday, August 15, 2018 at 4:30 PM EDT SOUTH EASTON, MA / ACCESSWIRE / August 15, 2018 / Pressure BioSc...
Source: ACCESSWIRE
Date: August, 15 2018 08:26
Pressure BioSciences, Inc. (PBIO) Receives Major Zacks Valuation Update
Zacks Small-Cap Research Report ups fair market value of PBIO stock by $2 per share Collaborative development project focused on liquid food preservation without chemical additives, extended shelf-life at room temperature and greater safety based upon PBIO’s patented Ultra Shear Te...
Source: NetworkNewsWire
Date: August, 10 2018 11:00
Pressure BioSciences, Inc. to Discuss Second Quarter 2018 Financial Results and Provide Business Update
SOUTH EASTON, MA / ACCESSWIRE / August 10, 2018 / Pressure BioSciences, Inc. (OTCQB: PBIO) (''PBI'' and the ''Company'') today announced that the Company will host a teleconference to discuss its Second Quarter 2018 financial results and to provide a business update. Anyone interested may li...
Source: ACCESSWIRE
Date: August, 10 2018 09:45

 


Last 5 Days Trading Activity

DateOpen PriceClose PriceHighLowVolume
2018-12-131.901.851.901.776,708
2018-12-121.801.901.951.7812,710
2018-12-111.991.771.991.774,734
2018-12-102.001.882.001.881,175
2018-12-071.962.002.001.7728,651

Last 5 Days Short Activity

DateShort VolumeTotal VolumeShort PercentageShort Indicator
2018-12-133,0646,70845.6768Short
2018-12-128,20212,71064.5319Short
2018-12-112,4504,23457.8649Short
2018-12-071,9508,65122.5407Cover
2018-12-069,29715,14061.4069Short

* Short Mode

Short Analysis provided by Squeeze Report. Get a complete short report on PBIO.


About Pressure BioSciences, Inc. (OTC: PBIO)

Logo for Pressure BioSciences, Inc. (OTC: PBIO)

Pressure BioSciences, Inc. OTCQB: PBIO develops, markets, and sells proprietary laboratory instrumentation and associated consumables to the estimated billion life sciences sample preparation market. Our products are based on the unique properties of both constant i.e., static and alternating i.e., pressure cycling technology, or PCT hydrostatic pressure. PCT is a patented enabling technology platform that uses alternating cycles of hydrostatic pressure between ambient and ultra high levels to safely and reproducibly control bio molecular interactions. To date, we have installed over PCT systems in approximately sites worldwide. There are over publications citing the advantages of the PCT platform over competitive methods, many from key opinion leaders. Our primary application development and sales efforts are in the biomarker discovery and forensics areas. Customers also use our products in other areas, such as drug discovery amp design, bio therapeutics characterization, soil amp plant biology, vaccine development, histology, and counter bioterror applications.

 

 

 

Current Management

  • Richard T. Schumacher / CEO, President
  • Joseph L Damasio, Jr. / Acting CFO, VP, Fin.
  • Edmund Ting / Senior VP, Engineering
  • Alexander Lazarev / VP, R amp D
  • Nathan P. Lawrence / VP, Sales amp Mktg.
  • Jeffrey N. Peterson / Chairman, Independent Director, Audit Committee Member, Compensation Committee Member, Nominating Committee Member
  • Vito J. Mangiardi / Independent Director, Audit Committee Member, Compensation Committee Member
  • Kevin A. Pollack / Independent Director, Audit Committee Member, Compensation Committee Member, Nominating Committee Member
  • Michael S. Urdea / Independent Director

Current Share Structure

  • Market Cap: $5,425,783 - 03/09/2018
  • Authorized: 100,000,000 - 08/31/2017
  • Issue and Outstanding: 1,154,422 - 11/07/2017
  • Float: 1,000,000 - 08/31/2017

 


Recent Filings from (OTC: PBIO)

Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: June, 15 2018
Quarterly report with a continuing view of a company's financial position
Filing Type: 10-QFiling Source: edgar
Filing Date: May, 15 2018
Annual report with a comprehensive overview of the company
Filing Type: 10-KFiling Source: edgar
Filing Date: April, 02 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: December, 27 2017
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: December, 18 2017
Official notification to shareholders of matters to be brought to a vote (Proxy)
Filing Type: DEF 14AFiling Source: edgar
Filing Date: November, 17 2017
Quarterly report with a continuing view of a company's financial position
Filing Type: 10-QFiling Source: edgar
Filing Date: November, 13 2017

 

 


Daily Technical Chart for (OTC: PBIO)

Daily Technical Chart for (OTC: PBIO)


Stay tuned for daily updates and more on (OTC: PBIO)

It most certainly could but even more important is the recent overwhelming interest in the company. Check out Investors Hub and search on Twitter

More to come on (OTC: PBIO)

Do your DD and if you choose, be ready to go!


 

The Research: All source information contained in this email is from the public sources mentioned below.

 

 
 

Thank you

DD Report
@DDReports

 

 


Disclaimer: DD Report publishes reports providing information on selected companies. DD Report is not a registered investment advisor or broker-dealer. This report is provided as an information service only, and the statements and opinions in this report should not be construed as an offer or solicitation to buy or sell any security. DD Report accepts no liability for any loss arising from an investors reliance on or use of this report. An investment in PBIO is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. DD Report has received no compensation for the publication and circulation of this report. DD Report does not own any shares of PBIO and does not buy, sell, or trade any shares of PBIO. This report contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Copyright 2018 by DD Report. All rights reserved. Our Full Disclaimer: https://dd.report/disclaimer/